16-hydroxycleroda-3,13(14)-dien-15,16-olide has been researched along with cytochrome c-t in 1 studies
| Studies (16-hydroxycleroda-3,13(14)-dien-15,16-olide) | Trials (16-hydroxycleroda-3,13(14)-dien-15,16-olide) | Recent Studies (post-2010) (16-hydroxycleroda-3,13(14)-dien-15,16-olide) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
|---|---|---|---|---|---|
| 13 | 0 | 8 | 11,809 | 21 | 5,125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Chia, YC; Huang, BM; Lee, WC; Liu, C | 1 |
1 other study(ies) available for 16-hydroxycleroda-3,13(14)-dien-15,16-olide and cytochrome c-t
| Article | Year |
|---|---|
16-Hydroxycleroda-3, 13-dien-15, 16-olide inhibits the proliferation and induces mitochondrial-dependent apoptosis through Akt, mTOR, and MEK-ERK pathways in human renal carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Diterpenes; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TOR Serine-Threonine Kinases | 2017 |